We’re looking for people living with Hidradenitis Suppurativa to take part in studies.
St Pancras Clinical Research is looking for people to take part in the development of new medicines for Hidradenitis Suppurativa. If you are interested in taking part in one of our studies, please register your interest by clicking the button below and a member of our team will be in touch.
Your safety and well-being is our priority. We operate under the international regulations governing clinical trials, and in full partnership with your GP.
Where can you take part?
London Clinic
Our comfortable, friendly clinic is located a short walk from Barbican underground station, 8 minutes from Farringdon and 12 minutes from Liverpool street.
Chester Clinic
Situated in Upton, Chester, our clinic is accessible easily via public transport or car, and is a 10 minute drive from Chester railway station.
SPCR and Hidradenitis Suppurativa
St Pancras Clinical Research was founded in 2016 by a group of medical experts with vast clinical trial experience across all phases – from ‘first-in-man’ studies, to post marketing.
SPCR has a particular interest in dermatology, specifically Hidradenitis Suppurativa, with a team of clinicians who have over 30 years of medical and research experience in the field.
We offer the opportunity to take part in clinical trials of new medicines for the treatment of Hidradenitis Suppurativa, and our patients have access to a range of specialist facilities and in-house consultants.
Our patients benefit from:
- A variety of diagnostic tests
- Early access to potential new medicines
- Access to specialist doctors and consultants
- Regular comprehensive check-ups
- Reimbursement for time and travel expenses
Am I eligible?
Please complete the form below to register your interest in our Hidradenitis Suppurativa studies. All participants in a clinical trial need to meet certain criteria to take part. If you are suitable based on your completed form, a member of the team will be in touch to talk to you in more detail about your symptoms and the trial options.
